Pfizer and BioNTech said Wednesday they have finalized an agreement to supply the European Union with another 200 million doses of their COVID-19 vaccine.
The U.S. and German companies said in a statement that the doses come on top of the 300 million vaccine doses initially ordered. The EU’s executive Commission has an option to request a further 100 million doses.
They said the 200 million doses are expected to be delivered this year, with an estimated 75 million of them in the second quarter.
The Pfizer-BioNTech vaccine was the first of three so far to be approved for use in the EU, which faces criticism for a slow start to its vaccination campaign compared with countries such as Israel, Britain and the United States. The other two EU-approved vaccines are from Moderna and AstraZeneca.
“We are working relentlessly to support the further roll-out of vaccination campaigns in Europe and worldwide by expanding manufacturing capacity,” Pfizer CEO Albert Bourla said.
BioNTech CEO Ugur Sahin noted that his company will initiate production at its new plant in Marburg, Germany, this month and has strengthened its manufacturing network with further partners.
“We are continuing to evaluate, together with governments, authorities and partners at all levels, how we might address an even higher future supply requirement for our vaccines,” he said.
Wednesday’s statement didn’t give financial details of the deal.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Pfizer-BioNTech to get EU 200 million more COVID-19 shots (2021, February 17)
retrieved 17 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Diet & Nutrition plan for a Head and Neck Cancer Patient - January 17, 2022
- COVID-19: HC urged to direct govt to give road map to vaccinate kids of 12 yrs and below - January 17, 2022
- 2,500 Delhi Police personnel infected, 767 cured of Covid since January 1 - January 17, 2022
- AstraZeneca vaccine trials show 3 doses give good protection against Omicron: Serum CEO - January 13, 2022
- Omicron Alert: FFD Launches Free Helpline For Diabetics - January 13, 2022
- Alkem Laboratories to Launch State of the Art Technology for Diabetic Foot Ulcer Management - January 13, 2022
- Metropolis Healthcare launches the 3rd edition of MedEngage Scholarship program to support aspiring young medical students - January 12, 2022
- Infections could surge 6 times higher due to omicron: Russia - January 12, 2022
- Makar Sankranti: Odisha bans religious gatherings; no holy dip at Haridwar - January 12, 2022
- Indonesia starts COVID boosters for elderly - January 12, 2022